Аннотация:Hypertrophic cardiomyopathy (HCM) is one of the most common genetic myocardial abnormalities defined by the presence of left ventricular hypertrophy (LVH)
in the absence of other potentially causative diseases [1]. Cardiac MR imaging (CMR) is useful for making a diagnosis and identifying the phenotypes of HCM, can
also contribute to risk stratification because of its accurate measurement of LVH, detection of “high-risk” phenotypes, and identification and quantitative